Cargando…
Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
Alzheimer’s disease (AD) is characterized by progressive neurodegeneration and is the most common cause of dementia. Immunotherapy has recently been regarded as a potential treatment for AD. This stems from the fact that the clinical and pathological findings from the active AD vaccine trial suggest...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918245/ https://www.ncbi.nlm.nih.gov/pubmed/27471709 http://dx.doi.org/10.2147/ITT.S49923 |